GENERATION BIO CO
GENERATION BIO CO logo
GBIO

GENERATION BIO CO (GBIO)

$5.160.78%

Live
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$5.01
Day's Range
$5.3
$3.96
52-Week Range
$17.93
1 month return0.0%
3 month return2.1%
1 year return70.18%
5 year return79.26%

Company Information

Generation Bio is an innovative genetic medicines company focused on creating a new class of non-viral gene therapy to provide durable, redosable treatments for people living with rare and prevalent diseases. The company's non-viral platform incorporates a proprietary, high-capacity DNA construct called closed-ended DNA, or ceDNA; a cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The platform is designed to enable multi-year durability from a single dose of ceDNA and to allow titration and redosing if needed. The ctLNP is engineered to deliver large genetic payloads, including multiple genes, to specific tissues to address a wide range of indications. The company's efficient, scalable manufacturing process supports Generation Bio's mission to extend the reach of gene therapy to more people, living with more diseases, in more places around the world.
OrganizationGENERATION BIO CO
Employees150
CEODr. Cameron Geoffrey McDonough M.D.
IndustryHealth Technology

Analyst Recommendation

based on 7 analysts ratings

Buy
71%
Buy
28%
Hold
0%
Sell

Based on 7 Wall street analysts offering stock ratings for GENERATION BIO CO(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 223.69%

Current

$5.15

Target

$16.67

Recommendation Trend

Based on 7 analyst

Current1M Ago3M Ago
Buy
5
10
10
Hold
2
3
3
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
341.7M
Book Value
$5.21
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-2.27
Wall Street Target Price
16.67

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
1.09
Enterprise Value
119.7M
Enterprise Value/Revenue
0.0
Enterprise Value/Ebitda
-0.9

Technicals

Beta
1.5
50 Day MA
5.48
200 Day MA
6.04

Institutional Holdings

T. Rowe Price Associates, Inc.

15.03%

FMR Inc

14.41%

Bellevue Group AG

6.1%

Artal Group S A

4.74%

Partner Fund Management LP

4.67%

Farallon Capital Management, L.L.C.

4.21%

Discover more

Frequently Asked Questions

What is GENERATION BIO CO share price today?

Can Indians buy GENERATION BIO CO shares?

How can I buy GENERATION BIO CO shares from India?

Can Fractional shares of GENERATION BIO CO be purchased?

What are the documents required to start investing in GENERATION BIO CO stocks?

What are today’s High and Low prices of GENERATION BIO CO?

What are today’s traded volumes of GENERATION BIO CO?

What is today’s market capitalisation of GENERATION BIO CO?

What is the 52 Week High and Low Range of GENERATION BIO CO?

How much percentage GENERATION BIO CO is down from its 52 Week High?

How much percentage GENERATION BIO CO is up from its 52 Week low?

What are the historical returns of GENERATION BIO CO?

Who is the Chief Executive Officer (CEO) of GENERATION BIO CO?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*